Molecular MRI of atherosclerosis: From mouse to man

MedicaMundi

Volumn 54, Issue 2, 2010, Pages 14-24

  Makowski, M ^a   Jansen, C ^a   Botnar, R ^a   Kim, W Y ^b   Maintz, D ^c   Spuentrup, E ^d  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

^c UNIVERSITY OF MÜNSTER   (Germany)

^d Department of Radiology   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM; EP 2104R; FERUMOXYTOL; FIBRIN; GADOFLUORINE; GADOFOSVESET; GADOLINIUM; GADOLINIUM CHELATE; GADOLINIUM PENTETATE; LIPID; MOLECULAR MARKER; NANOPARTICLE; NUCLEAR MAGNETIC RESONANCE IMAGING AGENT; SUPERPARAMAGNETIC IRON OXIDE; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE; UNCLASSIFIED DRUG;

ARTICLE; ATHEROSCLEROSIS; BLOOD FLOW VELOCITY; CLINICAL TRIAL; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DRUG DELIVERY SYSTEM; DRUG HALF LIFE; DRUG PROTEIN BINDING; DRUG TARGETING; DRUG UPTAKE; EXTRACELLULAR MATRIX; HUMAN; IMAGE ANALYSIS; INFLAMMATION; MACROPHAGE ACTIVATION; MOLECULAR IMAGING; MOLECULAR MECHANICS; MOLECULARLY TARGETED THERAPY; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; SIGNAL DETECTION; THROMBOGENESIS; THROMBOSIS;

EID: 78049496053     PISSN: 00257664     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (91)

1. Rosamond W, Flegal K, Furie K, Go A, Greenlund K, Haase N, et al. Heart Disease and Stroke Statistics - 2008 Update: A Report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2008; 117(4): e25-146.
2. Lloyd-Jones D, Adams R, Carnethon M, De Simone G, Ferguson TB, Flegal K, et al. Heart Disease and Stroke Statistics - 2009 Update: a Report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2009; 119(3): 480-486.
3. Virmani R, Burke AP, Farb A, Kolodgie FD. Pathology of the Vulnerable Plaque. J Am Coll Cardiol. 2006; 47(8 Suppl): C13-18.
4. Kubo T, Imanishi T, Takarada S, Kuroi A, Ueno S, Yamano T, et al. Assessment of Culprit Lesion Morphology in Acute Myocardial Infarction: Ability of Optical Coherence Tomography compared with Intravascular Ultrasound and Coronary Angioscopy. J Am Coll Cardiol. 2007; 50(10): 933-939.
5. Schoenhagen P, Ziada KM, Kapadia SR, Crowe TD, Nissen SE, Tuzcu EM. Extent and Direction of Arterial Remodeling in Stable Versus Unstable Coronary Syndromes: An Intravascular Ultrasound Study. Circulation. 2000; 101(6): 598-603.
6. Pundziute G, Schuijf JD, Jukema JW, Boersma E, Scholte AJ, Kroft LJ, et al. Noninvasive Assessment of Plaque Characteristics with Multislice Computed Tomography Coronary Angiography in Symptomatic Diabetic Patients. Diabetes Care. 2007; 30(5): 1113-1119.
7. Yeon SB, Sabir A, Clouse M, Martinezclark PO, Peters DC, Hauser TH, et al. Delayed-Enhancement Cardiovascular Magnetic Resonance Coronary Artery Wall Imaging: Comparison with Multislice Computed Tomography and Quantitative Coronary Angiography. J Am Coll Cardiol. 2007; 50(5): 441-447.
8. Maintz D, Ozgun M, Hoffmeier A, Fischbach R, Kim WY, Stuber M, et al. Selective Coronary Artery Plaque Visualization and Differentiation by Contrast-Enhanced Inversion prepared MRI. Eur Heart J. 2006; 27(14): 1732-1736.
9. Fayad ZA, Fuster V, Fallon JT, Jayasundera T, Worthley SG, Helft G, et al. Noninvasive In Vivo Human Coronary Artery Lumen and Wall Imaging using Black-Blood Magnetic Resonance Imaging. Circulation. 2000; 102(5): 506-510.
10. Kim WY, Stuber M, Bornert P, Kissinger KV, Manning WJ, Botnar RM. Three-Dimensional Black-Blood Cardiac Magnetic Resonance Coronary Vessel Wall Imaging Detects Positive Arterial Remodeling in Patients with Nonsignificant Coronary Artery Disease. Circulation. 2002; 106(3): 296-299.
11. Johnson GA, Benveniste H, Black RD, Hedlund LW, Maronpot RR, Smith BR. Histology by Magnetic Resonance Microscopy. Magn Reson Q. 1993; 9(1): 1-30.
12. Ross R. Atherosclerosis - an Inflammatory Disease. N Engl J Med. 1999; 340(2): 115-126.
13. Libby P, Ridker PM, Maseri A. Inflammation and Atherosclerosis. Circulation. 2002; 105(9): 1135-1143.
14. Falk E. Why do Plaques Rupture? Circulation. 1992; 86(6 Suppl): III30-42.
15. Falk E, Shah PK, Fuster V. Coronary Plaque Disruption. Circulation. 1995; 92(3): 657-671.
16. Welt FG, Rogers C. Inflammation and Restenosis in The Stent Era. Arterioscler Thromb Vasc Biol. 2002; 22(11): 1769-1776.
17. Jeremias A, Spies C, Herity NA, Pomerantsev E, Yock PG, Fitzgerald PJ, et al. Coronary Artery Compliance and Adaptive Vessel Remodelling in Patients with Stable and Unstable Coronary Artery Disease. Heart. 2000; 84(3): 314-319.
18. Katsuda S, Kaji T. Atherosclerosis and Extracellular Matrix. J Atheroscler Thromb. 2003; 10(5): 267-274.
19. Rekhter MD. Collagen Synthesis in Atherosclerosis: too much and not enough. Cardiovasc Res. 1999; 41(2): 376-384.
20. Krettek A, Sukhova GK, Libby P. Elastogenesis in Human Arterial Disease: a Role for Macrophages in Disordered Elastin Synthesis. Arterioscler Thromb Vasc Biol. 2003; 23(4): 582-587.
21. Strauss BH, Chisholm RJ, Keeley FW, Gotlieb AI, Logan RA, Armstrong PW. Extracellular Matrix Remodeling after Balloon Angioplasty Injury in a Rabbit Model of Restenosis. Circ Res. 1994; 75(4): 650-658.
22. Brasselet C, Durand E, Addad F, Al Haj Zen A, Smeets MB, Laurent-Maquin D, et al. Collagen and Elastin Cross-Linking: a Mechanism of Constrictive Remodeling after Arterial Injury. Am J Physiol Heart Circ Physiol. 2005; 289(5): H2228-2233.
23. Sluimer JC, Kolodgie FD, Bijnens AP, Maxfield K, Pacheco E, Kutys B, et al. Thin-Walled Microvessels in Human Coronary Atherosclerotic Plaques Show Incomplete Endothelial Junctions Relevance of Compromised Structural Integrity for Intraplaque Microvascular Leakage. J Am Coll Cardiol. 2009; 53(17): 1517-1527.
24. Lee RT, Schoen FJ, Loree HM, Lark MW, Libby P. Circumferential Stress and Matrix Metalloproteinase 1 in Human Coronary Atherosclerosis. Implications for Plaque Rupture. Arterioscler Thromb Vasc Biol. 1996; 16(8): 1070-1073.
25. Hansson GK, Robertson AK, Soderberg-Naucler C. Inflammation and Atherosclerosis. Annu Rev Pathol. 2006; 1: 297-329.
26. Kolodgie FD, Gold HK, Burke AP, Fowler DR, Kruth HS, Weber DK, et al. Intraplaque Hemorrhage and Progression of Coronary Atheroma. N Engl J Med. 2003; 349(24): 2316-2325.
27. Tavora F, Cresswell N, Li L, Ripple M, Burke A. Immunolocalisation of Fibrin in Coronary Atherosclerosis: Implications for Necrotic Core Development. Pathology.42(1): 15-22.
28. Gossl M, Versari D, Mannheim D, Ritman EL, Lerman LO, Lerman A. Increased Spatial Vasa Vasorum Density in the Proximal LAD in Hypercholesterolemia - Implications for Vulnerable Plaque-Development. Atherosclerosis. 2007; 192(2): 246-252.
29. Cheruvu PK, Finn AV, Gardner C, Caplan J, Goldstein J, Stone GW, et al. Frequency and Distribution of Thin-Cap Fibroatheroma and Ruptured Plaques in Human Coronary Arteries: a Pathologic Study. J Am Coll Cardiol. 2007; 50(10): 940-949.
30. Virmani R, Kolodgie FD, Burke AP, Finn AV, Gold HK, Tulenko TN, et al. Atherosclerotic plaque progression and vulnerability to rupture: angiogenesis as a source of intraplaque hemorrhage. Arterioscler Thromb Vasc Biol. 2005; 25(10): 2054-2061.
31. Xiao Q, Danton MJ, Witte DP, Kowala MC, Valentine MT, Degen JL. Fibrinogen Deficiency is Compatible with the Development of Atherosclerosis in Mice. J Clin Invest. 1998; 101(5): 1184-1194.
32. Bini A, Fenoglio JJ, Jr., Mesa-Tejada R, Kudryk B, Kaplan KL. Identification and Distribution of Fibrinogen, Fibrin, and Fibrin(ogen) Degradation Products in Atherosclerosis. Use of onoclonal Antibodies. Arteriosclerosis. 1989; 9(1): 109-121.
33. Sirol M, Itskovich VV, Mani V, Aguinaldo JG, Fallon JT, Misselwitz B, et al. Lipid-Rich Atherosclerotic Plaques Detected by Gadofluorine-Enhanced in vivo Magnetic Resonance Imaging. Circulation. 2004; 109(23): 2890-2896.
34. Weinmann HJ, Brasch RC, Press WR, Wesbey GE. Characteristics of Gadolinium-DTPA Complex: a Potential NMR Contrast Agent. AJR Am J Roentgenol. 1984; 142(3): 619-624.
35. Laniado M, Weinmann HJ, Schorner W, Felix R, Speck U. First Use of GdDTPA/Dimeglumine in Man. Physiol Chem Phys Med NMR. 1984; 16(2): 157-165.
36. Caravan P, Ellison JJ, McMurry TJ, Lauffer RB. Gadolinium(III) Chelates as MRI Contrast Agents: Structure, Dynamics, and Applications. Chem Rev. 1999; 99(9): 2293-2352.
37. Weissleder R, Elizondo G, Wittenberg J, Rabito CA, Bengele HH, Josephson L. Ultrasmall Superparamagnetic Iron Oxide: Characterization of a New Class of Contrast Agents for MR Imaging. Radiology. 1990; 175(2): 489-493.
38. Bach-Gansmo T. Ferrimagnetic Susceptibility Contrast Agents. Acta Radiol Suppl. 1993; 387: 1-30.
39. Nivorozhkin AL, Kolodziej AF, Caravan P, Greenfield MT, Lauffer RB, McMurry TJ. Enzyme-Activated Gd(3+) Magnetic Resonance Imaging Contrast Agents with a Prominent Receptor- Induced Magnetization Enhancement Angew Chem Int Ed Engl. 2001; 40(15): 2903-2906.
40. Caravan P. Strategies for Increasing the Sensitivity of Gadolinium based MRI Contrast Agents. Chemical Society Reviews. 2006; 35(6): 512.
41. Ferrucci JT, Stark DD. Iron Oxide-Enhanced MR Imaging of the Liver and Spleen: Review of the First 5 Years. AJR Am J Roentgenol. 1990; 155(5): 943-950.
42. Small WC, Nelson RC, Bernardino ME. Dual Contrast Enhancement of both T1- and T2-Weighted Sequences using Ultrasmall Superparamagnetic Iron Oxide. Magn Reson Imaging. 1993; 11(5): 645-654.
43. Taupitz M, Wagner S, Schnorr J, Kravec I, Pilgrimm H, Bergmann-Fritsch H, et al. Phase I Clinical Evaluation of Citrate-Coated Monocrystalline very small Superparamagnetic Iron Oxide Particles as a new Contrast Medium for Magnetic Resonance Imaging. Invest Radiol. 2004; 39(7): 394-405.
44. von Bary C, Preissel A, Wagner S, Makowski M, Schachoff S, Keithahn A, et al. MRI of Coronary Vessel Wall Injury in a Swine Model of Coronary Intervention using an Eletrostatically Stabilized VSOP Nanoparticle. Proceedings 16th Scientific Meeting, International Society for Magnetic Resonance in Medicine. 2008: 517.
45. Pouliquen D, Le Jeune JJ, Perdrisot R, Ermias A, Jallet P. Iron Oxide Nanoparticles for use as an MRI Contrast Agent: Pharmacokinetics and Metabolism. Magn Reson Imaging. 1991; 9(3): 275-283.
46. Schmitz SA, Coupland SE, Gust R, Winterhalter S, Wagner S, Kresse M, et al. Superparamagnetic Iron Oxide-Enhanced MRI of Atherosclerotic Plaques in Watanabe Hereditable Hyperlipidemic Rabbits. Invest Radiol. 2000; 35(8): 460-471.
47. Taupitz M, Schnorr J, Abramjuk C, Wagner S, Pilgrimm H, Hunigen H, et al. New Generation of Monomer-Stabilized very Small Superparamagnetic Iron Oxide Particles (VSOP) as Contrast Medium for MR Angiography: Preclinical Results in Rats and Rabbits. J Magn Reson Imaging. 2000; 12(6): 905-911.
48. Ruehm SG, Corot C, Vogt P, Kolb S, Debatin JF. Magnetic Resonance Imaging of Atherosclerotic Plaque with Ultrasmall Superparamagnetic Particles of Iron Oxide In Hyperlipidemic Rabbits. Circulation. 2001; 103(3): 415-422.
49. Kooi ME, Cappendijk VC, Cleutjens KB, Kessels AG, Kitslaar PJ, Borgers M, et al. Accumulation of Ultrasmall Superparamagnetic Particles of Iron Oxide in Human Atherosclerotic Plaques can be Detected by In Vivo Magnetic Resonance Imaging. Circulation. 2003; 107(19): 2453-2458.
50. Pirko I, Johnson A, Ciric B, Gamez J, Macura SI, Pease LR, et al. In Vivo Magnetic Resonance Imaging of Immune Cells in the Central Nervous System with Superparamagnetic Antibodies. Faseb J. 2004; 18(1): 179-182.
51. Yuan C, Kerwin WS, Ferguson MS, Polissar N, Zhang S, Cai J, et al. Contrast-Enhanced High Resolution MRI for Atherosclerotic Carotid Artery Tissue Characterization. J Magn Reson Imaging. 2002; 15(1): 62-67.
52. Kramer CM, Cerilli LA, Hagspiel K, DiMaria JM, Epstein FH, Kern JA. Magnetic Resonance Imaging Identifies the Fibrous Cap in Atherosclerotic Abdominal Aortic Aneurysm. Circulation. 2004; 109(8): 1016-1021.
53. Weinmann HJ, Ebert W, Misselwitz B, Schmitt-Willich H. Tissue-Specific MR Contrast Agents. Eur J Radiol. 2003; 46(1): 33-44.
54. Jaffer FA, Nahrendorf M, Sosnovik D, Kelly KA, Aikawa E, Weissleder R. Cellular Imaging of Inflammation in Atherosclerosis using Magnetofluorescent Nanomaterials. Mol Imaging. 2006; 5(2): 85-92.
55. Mulder WJ, Strijkers GJ, Griffioen AW, van Bloois L, Molema G, Storm G, et al. A Liposomal System for Contrast-Enhanced Magnetic Resonance Imaging of Molecular Targets. Bioconjug Chem. 2004; 15(4): 799-806.
56. Mulder WJ, Strijkers GJ, Briley-Saboe KC, Frias JC, Aguinaldo JG, Vucic E, et al. Molecular Imaging of Macrophages in Atherosclerotic Plaques using Bimodal PEG-Micelles. Magn Reson Med. 2007; 58(6): 1164-1170.
57. Amirbekian V, Lipinski MJ, Briley-Saebo KC, Amirbekian S, Aguinaldo JG, Weinreb DB, et al. Detecting and Assessing Macrophages In Vivo to Evaluate Atherosclerosis Noninvasively using Molecular MRI. Proceedings of the National Academy of Sciences of the United States of America. 2007; 104(3): 961-966.
58. Makowski M, Blume U, Wiethoff A, Jansen C, Lazewatsky J, Robinson S, Botnar R. In Vivo Molecular MRI of Atherosclerotic Plaque Progression in Mice using a Novel Elastin-Binding Contrast Agent. Paper presented at: Proceedings 17th Scientific Meeting, International Society for Magnetic Resonance in Medicine; April, 2009; Honolulu.
59. von Bary C, Preissel A, Spuentrup E, Keithahn A, Schachoff S, Robinson S, et al. Molecular MRI of Vascular Remodeling in a Swine Model of Coronary Injury using an Elastin-Binding Contrast Agent. Proceedings 16th Scientific Meeting, International Society for Magnetic Resonance in Medicine. 2008: 321.
60. Moody AR. Magnetic Resonance Direct Thrombus Imaging. Journal of Thrombosis and Haemostasis. 2003; 1(7): 1403-1409.
61. Moody AR, Murphy RE, Morgan PS, Martel AL, Delay GS, Allder S, et al. Characterization of Complicated Carotid Plaque with Magnetic Resonance Direct Thrombus Imaging in Patients with Cerebral Ischemia. Circulation. 2003; 107(24): 3047-3052.
62. Murphy RE, Moody AR, Morgan PS, Martel AL, Delay GS, Allder S, et al. Prevalence of Complicated Carotid Atheroma as Detected by Magnetic Resonance Direct Thrombus Imaging in Patients with Suspected Carotid Artery Stenosis and Previous Acute Cerebral Ischemia. Circulation. 2003; 107(24): 3053-3058.
63. van Beek EJ, Wild JM, Fink C, Moody AR, Kauczor HU, Oudkerk M. MRI for the Diagnosis of Pulmonary Embolism. J Magn Reson Imaging. 2003; 18(6): 627-640.
64. Toussaint JF, LaMuraglia GM, Southern JF, Fuster V, Kantor HL. Magnetic Resonance Images Lipid, Fibrous, Calcified, Hemorrhagic, and Thrombotic Components of Human Atherosclerosis In Vivo. Circulation. 1996; 94(5): 932-938.
65. Yuan C, Petty C, O'Brien KD, Hatsukami TS, Eary JF, Brown BG. In Vitro and In Situ Magnetic Resonance Imaging Signal Features of Atherosclerotic Plaque-Associated Lipids. Arterioscler Thromb Vasc Biol. 1997; 17(8): 1496-1503.
66. Fayad ZA, Fallon JT, Shinnar M, Wehrli S, Dansky HM, Poon M, et al. Noninvasive In Vivo High-Resolution Magnetic Resonance Imaging of Atherosclerotic Lesions in Genetically Engineered Mice. Circulation. 1998; 98(15): 1541-1547.
67. Rapoport S, Sostman HD, Pope C, Camputaro CM, Holcomb W, Gore JC. Venous Clots - Evaluation with MR Imaging. Radiology. 1987; 162(2): 527-530.
68. Moody AR, Morgan PS, Fraser D, Hunt BJ. T1 Reducing Properties of Methaemoglobin: Application to Direct MR Thrombus Imaging. Proceedings of the ISMRM 8th scientific meeting. 2000: 1.
69. McGuinness CL, Humphries J, Waltham M, Burnand KG, Collins M, Smith A. Recruitment of Labelled Monocytes by Experimental Venous Thrombi. Thromb. Haemost. 2001; 85(6): 1018-1024.
70. Modarai B, Burnand KG, Humphries J, Waltham M, Smith A. The Role of Neovascularisation in the Resolution of Venous thrombus. Thromb. Haemost. 2005; 93(5): 801-809.
71. Fraser DGW, Moody AR, Morgan PS, Martel AL, Davidson I. Diagnosis of Lower-Limb Deep Venous Thrombosis: A Prospective Blinded Study of Magnetic Resonance Direct Thrombus Imaging. Annals of Internal Medicine. 2002; 136(2): 89-98.
72. Moody AR. Direct Imaging of Deep-Vein Thrombosis with Magnetic Resonance Imaging. Lancet. 1997; 350(9084): 1073-1073.
73. Kelly J, Hunt BJ, Moody A. Magnetic Resonance Direct Thrombus Imaging: a Novel Technique for Imaging Venous Thromboemboli. Thromb. Haemost. 2003; 89(5): 773-782.
74. Moody AR, Pollock JG, O'Connor AR, Bagnall M. Lower-Limb Deep Venous Thrombosis: Direct MR Imaging of the Thrombus. Radiology. 1998; 209(2): 349-355.
75. Schmitz SA, O'Regan DP, Gibson D, Cunningham C, Fitzpatrick J, Allsop J, et al. Magnetic Resonance Direct Thrombus Imaging at 3 T Field Strength in Patients with Lower Limb Deep Vein Thrombosis: a Feasibility Study. Clinical Radiology. 2006; 61(3): 282-286.
76. Griffioen AW, Molema G. Angiogenesis: Potentials for Pharmacologic Intervention in the Treatment of Cancer, Cardiovascular Diseases, and Chronic Inflammation. Pharmacol Rev. 2000; 52(2): 237-268.
77. Choudhury RP, Fuster V, Fayad ZA. Molecular, Cellular and Functional Imaging of Atherothrombosis. Nat Rev Drug Discov. 2004; 3(11): 913-925.
78. Purushothaman KR, Sanz J, Zias E, Fuster V, Moreno PR. Atherosclerosis Neovascularization and Imaging. Curr Mol Med. 2006; 6(5): 549-556.
79. Libby P. Inflammation in Atherosclerosis. Nature. 2002; 420(6917): 868-874.
80. Winter PM, Neubauer AM, Caruthers SD, Harris TD, Robertson JD, Williams TA, et al. Endothelial Alpha(v)Beta3 Integrin-Targeted Fumagillin Nanoparticles Inhibit Angiogenesis in Atherosclerosis. Arterioscler Thromb Vasc Biol. 2006; 26(9): 2103-2109.
81. Kerwin WS, O'Brien KD, Ferguson MS, Polissar N, Hatsukami TS, Yuan C. Inflammation in Carotid Atherosclerotic Plaque: a Dynamic Contrast-Enhanced MR Imaging Study. Radiology. 2006; 241(2): 459-468.
82. Flacke S, Fischer S, Scott MJ, Fuhrhop RJ, Allen JS, McLean M, et al. Novel MRI Contrast Agent for Molecular Imaging of Fibrin: Implications for Detecting Vulnerable Plaques. Circulation. 2001; 104(11): 1280-1285.
83. Botnar RM, Buecker A, Wiethoff AJ, Parsons EC, Jr., Katoh M, Katsimaglis G, et al. In Vivo Magnetic Resonance Imaging of Coronary Thrombosis using a Fibrin-Binding Molecular Magnetic Resonance Contrast Agent. Circulation. 2004; 110(11): 1463-1466.
84. Botnar RM, Perez AS, Witte S, Wiethoff AJ, Laredo J, Hamilton J, et al. In Vivo Molecular Imaging of Acute and Subacute Thrombosis using a Fibrin-Binding Magnetic Resonance Imaging Contrast Agent. Circulation. 2004; 109(16): 2023-2029.
85. Spuentrup E, Buecker A, Katoh M, Wiethoff AJ, Parsons EC, Jr., Botnar RM, et al. Molecular Magnetic Resonance Imaging of Coronary Thrombosis and Pulmonary Emboli With a Novel Fibrin-Targeted Contrast Agent. Circulation. 2005.
86. Yu X, Song SK, Chen J, Scott MJ, Fuhrhop RJ, Hall CS, et al. High-Resolution MRI Characterization of Human Thrombus using a Novel Fibrin-Targeted Paramagnetic Nanoparticle Contrast Agent. Magn Reson Med. 2000; 44(6): 867-872.
87. Spuentrup E, Botnar RM, Wiethoff A, Ibrahim T, Sebastin K, Katho M, et al. MR Imaging of Thrombi using EP-2104R, a Fibrin Specific Contrast Agent: Initial Results in Patients. European Radiology. 2008; 18(9): 1995-2005 (1911).
88. Sirol M, Moreno P, Purushothaman K, Vucic E, Amirbekian V, Weinmann H, et al. Increased Neovascularization in Advanced Lipid-Rich Atherosclerotic Lesions Detected by Gadofluorine-MEnhanced MRI: Implications for Plaque Vulnerability. Circulation: Cardiovascular Imaging. 2009; 2(5): 391-396.
89. Chen W, Vucic E, Leupold E, Mulder WJ, Cormode DP, Briley-Saebo KC, et al. Incorporation of an apoE-derived Lipopeptide in High-Density Lipoprotein MRI Contrast Agents for Enhanced Imaging of Macrophages in Atherosclerosis. Contrast Media Mol Imaging. 2008; 3(6): 233-242.
90. Falk E. Pathogenesis of Atherosclerosis. J Am Coll Cardiol. 2006; 47(8 Suppl): C7-12.
91. Spuentrup E, Botnar RM, Wiethoff AJ, Ibrahim T, Kelle S, Katoh M, et al. MR Imaging of Thrombi using EP-2104R, a Fibrin-Specific Contrast Agent: Initial Results in Patients. Eur Radiol. 2008.